Insider buying last 90 days
No open-market insider purchases were filed for HSIC in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every HSIC insider filing, plotted on the chart in Gekko.Open HSIC in Gekko
NASDAQ: HSIC
Henry Schein (HSIC) Stock Analysis & Forecast
Sep 28 close
$85.99−0.38 (−0.4%)
Gekko Brief
AI summaryHenry Schein moves this week on raised guidance: the company lifted its fiscal 2026 sales growth outlook to 4.5%-5.5% and non-GAAP diluted EPS guidance to $5.29-$5.39, following Q2 2026 sales of $3.46 billion, up 6.7% year-over-year, with non-GAAP EPS up 15.5% to $1.27. Coverage also points to dental merchandise gains, strategic acquisitions, an expanded revolving credit facility, and AI-enabled technology platforms as contributors, with the stock described as outperforming the Dow Jones Industrials Average year-to-date and over the past 52 weeks.
The stock closes at $85.99, down 0.4%, sitting between its 50-day average of $87.77 and 200-day average of $80.10, and below its 52-week high of $92.18. The GekkoIndex reads 60.1, placing HSIC in the Accumulation zone, though the index has slipped 7.6 over the prior five sessions. Price sits 3.7% above Gekko Fair Value of $82.92.
The next earnings date falls on 3 November 2026, 35 days out, beyond a typical 20-trading-day holding window; the prior quarter saw an EPS beat of $1.32 against a $1.22 estimate with a 0.5% reaction. Smart-money and options activity show no recorded signals in their respective windows, though one billionaire holder and one trailblazer holder are noted. Seasonality over the next 20 trading days has averaged -2.1% across 5 years, rising in 2 of them. Analyst consensus among 14 firms includes 9 buy and 5 hold ratings, with a consensus target of $97.27.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Henry Schein price vs fair value
Close $85.99200-day averageGekko Fair Value $82.92
Henry Schein quick facts
- Market cap
- $9.80B
- P/E ratio
- 25.2
- Forward P/E
- 14.8
- EPS, TTM
- $3.43
- Revenue, TTM
- $13.60B
- Profit margin
- 3%
- Dividend yield
- —
- Beta
- 0.81
- Volume
- 971,162 avg 1.09M
- 1-year return
- +31.0%
- Typical daily move
- ±2%
- Typical 20-day move
- ±4.5%
- 50-day average
- $87.77
- 200-day average
- $80.10
- Next earnings
- Nov 3
- Shares outstanding
- 113.9M
Henry Schein swing-trade checklist
Henry Schein scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
- Trendmixed
Averages disagree
Close $85.99 sits between the 50-day ($87.77) and 200-day ($80.10) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
60.1, Accumulation
Reading 60.1 is in the Accumulation zone.
See the GekkoIndex - Fair valuemixed
3.7% above
Price is within 5% of Gekko Fair Value (3.7% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 35 days
Next report Nov 3, 2026, 35 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−2.1% on average
From this point in the calendar, the next 20 trading days averaged −2.1% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Henry Schein stock chart and price history
Henry Schein closed at $85.99 on Sep 28, 2026, +31.0% over the past year, inside a 52-week range of $61.95 to $92.18.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −4.8%
- 3 months
- +2.0%
- 6 months
- +19.3%
- 1 year
- +31.0%
The full HSIC chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open HSIC in Gekko
Follow Henry Schein through every session
Put HSIC on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track HSIC in GekkoFree for 7 days. No credit card required.
About Henry Schein
Henry Schein provides a wide range of healthcare products and services to customers that include dental practices and labs, physician offices, government agencies, and other institutional and alternative care providers worldwide. It has built recognition around supplying dental items like infection control materials, impression materials, composites, anesthetics, and artificial teeth, plus tools such as handpieces, chairs, delivery systems, X-ray machines, and digital restoration equipment, along with protective gear and repair services for that equipment. It also moves a large volume of medical supplies, covering branded and generic drugs, vaccines, surgical tools, diagnostic kits, infection prevention items, imaging equipment, and nutritional products.
Its business is split into two segments. One, Health Care Distribution, centers on getting these dental and medical goods to customers along with repair work. The other, Technology and Value-Added Services, offers practice management software built for dental and medical providers, plus support like non-recourse financing, electronic tools, network and technology infrastructure help, hardware servicing, training programs, and consulting.
Henry Schein traces back to 1932 and runs its headquarters out of Melville, New York. Shares trade on the NASDAQ under the ticker HSIC.
- Listed
- NASDAQ
- Sector
- Distribution services
- Industry
- Medical distributors
- Website
- henryschein.com
Henry Schein GekkoIndex: the smart money zone
Henry Schein’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 60.1, in the Accumulation zone, down 7.6 points over five sessions.
60.1Accumulation
Down 7.6 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 28 | +2.4% | +4.2% | ||
| Accumulation (current zone) | 219 | +0.7% | +3.0% | ||
| Neutral | 397 | −0.2% | −0.6% | ||
| Distribution | 27 | −0.2% | −2.1% | ||
| Selling | 1 | Too few readings yet | |||
Average HSIC share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the HSIC price, zone by zone.Track HSIC in Gekko
Is Henry Schein stock overvalued? Gekko Fair Value
Henry Schein trades 3.7% above Gekko Fair Value of $82.92, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Henry Schein shares are worth, recalculated every trading day.
$82.92
Gekko Fair Value, Sep 29, 2026
3.7% above fair value · About fair value
Gekko Fair Value on every chart, with the gap to price updating daily.Open HSIC in Gekko
Henry Schein insider and Congress trading
No open-market insider purchases were filed for Henry Schein, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in HSIC were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for HSIC, plotted on the chart in Gekko.Open HSIC in Gekko
Buybacks
Henry Schein has been buying back its own shares.
- Bought back, quarter ended Jun 27, 2026
- $200.0M
- As a share of market cap
- 2.04%
- Trailing four quarters
- $728.0M
From company filings.
Hedge funds and billionaires quarter ended Jun 30
2of the funds Gekko tracks hold HSIC.
2added0opened0trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko
Henry Schein earnings: next date and track record
Henry Schein reports on Nov 3, 2026 (35 days away), and beat the EPS estimate in 6 of its last 8 reports.
Next earnings report
Nov 3, 2026
35 days away
- EPS estimate
- $1.34
- Revenue estimate
- $3.47B
6 of 8reports beat the EPS estimate
±5%average move across the report
4 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Mar 31, 2026 AI summary
- What they said
- HSIC reported fourth quarter 2025 results with continuing sales momentum achieving the highest quarterly sales. The company is undergoing a leadership transition with Fred Lowry becoming CEO designate, joining from Thermo Fisher Scientific where he spent 20 years. Management emphasized successful transformation management and significant growth opportunities ahead.
- Guidance
- No specific forward-looking guidance or revenue/earnings targets were provided in this excerpt. Management expressed confidence in accelerating strategy implementation under new leadership.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Mar 31, 2026 | $1.32 est $1.22 | $3.44B est $3.35B | +0.5% |
| Nov 4, 2025 | $1.38 est $1.27 | $3.34B est $3.34B | +11.4% |
| Aug 5, 2025 | $1.10 est $1.18 | $3.24B est $3.28B | −5.3% |
| May 5, 2025 | $1.15 est $1.11 | $3.17B est $3.22B | +1.4% |
| Feb 25, 2025 | $1.19 est $1.21 | $3.19B est $3.29B | −6.6% |
| Nov 5, 2024 | $1.22 est $1.17 | $3.17B est $3.36B | −3.2% |
| Aug 6, 2024 | $1.23 est $1.22 | $3.14B est $3.28B | −5.4% |
| May 7, 2024 | $1.10 est $1.01 | $3.17B est $3.21B | +6.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Henry Schein stock forecast and analyst price targets
Analysts’ average 12-month price target for Henry Schein is $97.27, +13.1% from the last close, from 14 firms rating the stock in the last 90 days.
$97.27consensus 12-month target, +13.1% from the last close
Now $85.99Avg $97.27
Low $85High $112
Each firm’s latest rating in the last 90 days: 14 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 18 | Piper Sandler | $104 | +20.9% |
| Sep 10 | Bank of America Securities | $110 | +27.9% |
| Aug 19 | BTIG | $110 | +27.9% |
| Aug 6 | J.P. Morgan | $102 | +18.6% |
| Aug 5 | Citi | $112 | +30.2% |
+3.0%average 20-day move after past Accumulation readings
−2.1%average move over the next 20 trading days in the last 5 years
±2%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Henry Schein seasonality: the next 20 trading days
Over the next 20 trading days from Sep 26, Henry Schein averaged −2.1% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.5% | 3 of 5 |
| Next 10 trading days | −0.4% | 3 of 5 |
| Next 15 trading days | −1.5% | 2 of 5 |
| Next 20 trading days | −2.1% | 2 of 5 |
| Next 30 trading days | +0.9% | 3 of 5 |
For scale, HSIC’s typical 20-trading-day move in either direction is about 4.5%.
Henry Schein market cap and key statistics
Henry Schein’s market cap is $9.80B, with a P/E ratio of 25.2 and revenue of $13.60B over the last twelve months.
Valuation
- Market cap
- $9.80B
- P/E ratio
- 25.2
- Forward P/E
- 14.8
- EPS, TTM
- $3.43
- Gekko Fair Value
- $82.92
Trading
- Volume
- 971,162
- Avg volume, 20 days
- 1.09M
- 52-week high
- $92.18
- 52-week low
- $61.95
- Shares outstanding
- 113.9M
Financials
- Revenue, TTM
- $13.60B
- Profit margin
- 3%
- Return on equity
- 8.9%
- Quarterly earnings growth, YoY
- +17.1%
Risk and income
- Beta
- 0.81
- Typical daily move
- ±2%
- Typical 20-day move
- ±4.5%
Henry Schein stock news this week
Coverage of Henry Schein this week reads positive: 10 positive, 2 neutral and 1 negative headlines.
- Henry Schein stock reflects raised 2026 guidance at USD 86.37AD HOC NEWS, Sep 28
- Henry Schein Q2FY26 Results: Non-GAAP EPS up 15.5%, guidance raisedscanx.trade, Sep 25
- Is Henry Schein Stock Outperforming the Dow?inkl, Sep 25
- Transcript: Henry Schein Q2 2026 Earnings Conference CallBenzinga, Sep 25
- Henry Schein stock trades below its yearly high after Q2 figuresAD HOC NEWS, Sep 25
- Henry Schein stock heads into the open after closing at USD 85.05AD HOC NEWS, Sep 25
Henry Schein peers
Henry Schein’s 3 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MCKMcKesson | Accumulation | 14.1% below |
| CORCencora | Accumulation | 27.4% below |
| CAHCardinal Health | Buying | 42.1% below |
A peer links to its own page where one exists.
Henry Schein stock FAQ
What is Henry Schein’s market cap?
Henry Schein’s market cap is $9.80B at the Sep 28, 2026 close of $85.99, with 113.9M shares outstanding. The shares trade on a P/E ratio of 25.2.
What is the Henry Schein stock forecast?
The consensus analyst 12-month price target for Henry Schein is $97.27, +13.1% from the last close. Of the 14 firms that rated the stock in the last 90 days, 9 rate it a buy, 5 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Henry Schein stock overvalued or undervalued?
On Gekko’s estimate Henry Schein is about fair value: the Sep 28, 2026 close of $85.99 is 3.7% above Gekko Fair Value of $82.92. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Henry Schein report earnings next?
Henry Schein is expected to report on Nov 3, 2026 (35 days away). Analysts expect earnings of $1.34 per share on revenue of $3.47B. Henry Schein beat the earnings estimate in 6 of its last 8 reports, moving 5% on average across the report.
What is Henry Schein’s 52-week high and low?
Henry Schein’s 52-week high is $92.18 and its 52-week low is $61.95; it closed at $85.99 on Sep 28, 2026, +31.0% over the past year. Over the last five years the shares peaked at $92.68 on Apr 14, 2022.
Is Henry Schein stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (gekkoindex and earnings risk), 2 as mixed (trend and fair value) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Henry Schein the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.